{{Rsnum
|rsid=6873545
|Gene=GHR
|Chromosome=5
|position=42631162
|Orientation=plus
|GMAF=0.2952
|Gene_s=GHR
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 39.8 | 52.2
| HCB | 1.5 | 31.4 | 67.2
| JPT | 0.9 | 27.4 | 71.7
| YRI | 18.4 | 56.5 | 25.2
| ASW | 28.1 | 57.9 | 14.0
| CHB | 1.5 | 31.4 | 67.2
| CHD | 0.9 | 27.5 | 71.6
| GIH | 4.0 | 32.7 | 63.4
| LWK | 15.5 | 47.3 | 37.3
| MEX | 1.7 | 31.0 | 67.2
| MKK | 19.2 | 51.9 | 28.8
| TSI | 2.9 | 43.1 | 53.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23812803
|Title=The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis
}}

{{PMID Auto
|PMID=24114431
|Title=SNPs within the GH signaling pathway are associated with the early IGF-I response to GH replacement therapy in GHD adults
}}

{{PMID Auto
|PMID=20219401
|Title=Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP.
}}

{{PMID Auto
|PMID=20445798
|Title=Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}